Agilent Technologies (NYSE:A) Coverage Initiated by Analysts at Deutsche Bank Aktiengesellschaft

Analysts at Deutsche Bank Aktiengesellschaft initiated coverage on shares of Agilent Technologies (NYSE:A) in a research note issued on Monday, Briefing.com reports. The brokerage set a “buy” rating and a $190.00 price target on the medical research company’s stock. Deutsche Bank Aktiengesellschaft‘s target price suggests a potential upside of 9.84% from the company’s current price.

Several other equities analysts have also commented on A. The Goldman Sachs Group upped their price target on shares of Agilent Technologies from $175.00 to $185.00 and gave the stock a “buy” rating in a research report on Monday, September 21st. Royal Bank Of Canada lifted their price objective on shares of Agilent Technologies from $155.00 to $185.00 and gave the company an “outperform” rating in a research report on Thursday, August 27th. Jefferies Financial Group initiated coverage on shares of Agilent Technologies in a research note on Thursday, July 9th. They set a “hold” rating and a $135.00 target price for the company. Robert W. Baird boosted their target price on shares of Agilent Technologies from $180.00 to $195.00 and gave the company an “outperform” rating in a research note on Thursday, October 8th. Finally, Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, October 17th. Eighteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $181.45.

Agilent Technologies Stock Down 0.1%

Shares of Agilent Technologies stock opened at $172.98 on Monday. The stock has a market capitalization of $48.77 billion, a price-to-earnings ratio of 34.05, a PEG ratio of 2.63 and a beta of 1.21. Agilent Technologies has a twelve month low of $108.35 and a twelve month high of $179.10. The company has a current ratio of 2.05, a quick ratio of 1.56 and a debt-to-equity ratio of 0.50. The business’s 50 day simple moving average is $161.48 and its 200-day simple moving average is $139.79.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.49 by $0.13. The business had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The business’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.37 EPS. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Equities research analysts forecast that Agilent Technologies will post 6.20 earnings per share for the current year.

Insider Activity at Agilent Technologies

In related news, Director Mikael Dolsten sold 634 shares of Agilent Technologies stock in a transaction dated Friday, September 4th. The shares were sold at an average price of $151.38, for a total transaction of $95,974.92. Following the sale, the director directly owned 4,924 shares in the company, valued at $745,395.12. The trade was a 11.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Hedge Funds Weigh In On Agilent Technologies

A number of institutional investors and hedge funds have recently bought and sold shares of A. Bank of New York Mellon Corp boosted its stake in Agilent Technologies by 87.4% during the second quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock valued at $695,227,000 after buying an additional 2,440,360 shares in the last quarter. Legal & General Group Plc bought a new stake in Agilent Technologies in the second quarter worth about $260,101,000. Bank of America Corp DE bought a new position in shares of Agilent Technologies during the 2nd quarter valued at about $213,269,000. Man Group plc acquired a new position in shares of Agilent Technologies in the 2nd quarter worth approximately $179,257,000. Finally, Primecap Management Co. CA acquired a new position in shares of Agilent Technologies in the 2nd quarter worth approximately $176,318,000.

About Agilent Technologies

Agilent Technologies, Inc is a global provider of analytical laboratory instruments, software, services and consumables. The company serves customers in the pharmaceutical, biotechnology, chemical, food, environmental, energy and academic research sectors, as well as diagnostic and clinical laboratories.

Agilent’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic instruments, laboratory automation products, genomic and cell analysis solutions, and related software.